0 التعليقات
0 المشاركات
8 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
أخر الأخبار
- استكشف
-
الصفحات
-
المدونات
-
Courses
-
الافلام
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Autoimmune Polyglandular Syndrome Type 1 Market Forecasted to Reach $363M by 2032Introspective Market Research (IMR) today announced the release of its Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market Report, projecting a consistent expansion in this rare but clinically significant autoimmune disorder. IMR’s analysis estimates that the APS-1 market — recently valued at USD 289.1 million (2025) according to — will grow to approximately USD...0 التعليقات 0 المشاركات 420 مشاهدة 0 معاينة
-
Campomelic Syndrome Treatment Market - Overview and Outlook by Potential GrowthIntrospective Market Research, a leader in pharmaceutical and healthcare intelligence, today published its deep-dive analysis into the Global Campomelic Syndrome Treatment Market. Campomelic Syndrome (CS) is a rare and often life-threatening genetic disorder characterized by severe skeletal malformations, which necessitates intensive supportive and specialized care. The market, which focuses on...0 التعليقات 0 المشاركات 366 مشاهدة 0 معاينة
-
Cell Therapy Manufacturing Market: Global Growth & AnalysisIntrospective Market Research, a global authority in biotechnology and healthcare analysis, today released its comprehensive report on the Global Cell Therapy Manufacturing Market. This critical sector, which encompasses the complex processes of cell acquisition, culture, expansion, and testing for regenerative medicine, is transitioning from a niche laboratory process to an industrialized...0 التعليقات 0 المشاركات 440 مشاهدة 0 معاينة
-
Osteogenesis Imperfecta Treatment Market - Trend, Growth, Forecast 2024–2032Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market. The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million in...0 التعليقات 0 المشاركات 402 مشاهدة 0 معاينة